Crescent Sterling’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Buy
19,886
+841
+4% +$122K 2.61% 11
2026
Q1
$2.75M Buy
19,045
+524
+3% +$79.4K 2.66% 11
2025
Q4
$2.65M Buy
18,521
+218
+1% +$32.1K 2.72% 12
2025
Q3
$2.81M Sell
18,303
-129
-0.7% -$20.1K 2.96% 11
2025
Q2
$2.94M Sell
18,432
-2,869
-13% -$468K 3.29% 8
2025
Q1
$3.63M Sell
21,301
-1,061
-5% -$178K 3.72% 8
2024
Q4
$3.75M Sell
22,362
-786
-3% -$134K 3.85% 5
2024
Q3
$4.01M Sell
23,148
-938
-4% -$159K 3.82% 5
2024
Q2
$3.97M Sell
24,086
-469
-2% -$76.7K 3.81% 5
2024
Q1
$3.98M Sell
24,555
-229
-0.9% -$35.9K 3.63% 6
2023
Q4
$3.63M Sell
24,784
-733
-3% -$109K 3.62% 6
2023
Q3
$3.72M Sell
25,517
-3,118
-11% -$476K 3.94% 6
2023
Q2
$4.35M Buy
28,635
+178
+0.6% +$26.8K 4.12% 6
2023
Q1
$4.23M Buy
28,457
+2,267
+9% +$324K 4.11% 6
2022
Q4
$3.97M Buy
+26,190
New +$3.67M 4.26% 6

Other funds holding PG

Crescent Sterling's PG Position: Q2 2026 in Review

Crescent Sterling increased its Procter & Gamble (PG) stake by 4.4% in Q2 2026, buying an estimated $122K and bringing the position to 19,886 shares worth $2.92M. The position accounts for 2.61% of the portfolio, ranked #11.

Crescent Sterling first reported a position in PG in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.35M in Q2 2023. 1,168 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Crescent Sterling held 19,886 shares of Procter & Gamble worth $2.92M as of Q2 2026.
  • Crescent Sterling bought 841 Procter & Gamble shares in Q2 2026, an estimated $122K.
  • Procter & Gamble made up 2.61% of Crescent Sterling's portfolio in Q2 2026, its #11 holding.
  • Crescent Sterling first reported a position in Procter & Gamble in Q4 2022 and has held it in 15 quarters since.
  • Crescent Sterling's Procter & Gamble position peaked at $4.35M in Q2 2023.
  • 1,168 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Crescent Sterling's 13F filing for Q2 2026, filed 7 Jul 2026.